Use este identificador para citar ou linkar para este item:
http://repositorio.ufla.br/jspui/handle/1/41546
Registro completo de metadados
Campo DC | Valor | Idioma |
---|---|---|
dc.creator | Serafin, Marissa B. | - |
dc.creator | Bottega, Angelita | - |
dc.creator | Foletto, Vitória S. | - |
dc.creator | Rosa, Taciéli F. da | - |
dc.creator | Hörner, Andreas | - |
dc.creator | Hörner, Rosmari | - |
dc.date.accessioned | 2020-06-23T15:50:59Z | - |
dc.date.available | 2020-06-23T15:50:59Z | - |
dc.date.issued | 2020-06 | - |
dc.identifier.citation | SERAFIN, M. B. et al. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents, [S.l.], v. 55, n. 6, June 2020. | pt_BR |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0924857920301266 | pt_BR |
dc.identifier.uri | http://repositorio.ufla.br/jspui/handle/1/41546 | - |
dc.description.abstract | Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease. | pt_BR |
dc.language | en_US | pt_BR |
dc.publisher | Elsevier | pt_BR |
dc.rights | restrictAccess | pt_BR |
dc.source | International Journal of Antimicrobial Agents | pt_BR |
dc.subject | COVID-19 | pt_BR |
dc.subject | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | pt_BR |
dc.title | Drug repositioning is an alternative for the treatment of coronavirus COVID-19 | pt_BR |
dc.type | Artigo | pt_BR |
Aparece nas coleções: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Arquivos associados a este item:
Não existem arquivos associados a este item.
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.